Evidence map›Paper›PMID 37483712›Full record

ArticleHeliyon2023

Interplay of multifractal dynamics between shadow policy rates and stock markets.

Faheem Aslam, Wahbeeah Mohti, Haider Ali, Paulo Ferreira

Abstract read
In one paragraph

Article in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Faheem AslamDepartment of Management Sciences, COMSATS University Islamabad, Park Road, 45550 Islamabad, Pakistan.
Wahbeeah MohtiDepartment of Business Administration, Iqra University Islamabad Campus Pakistan.
Haider AliDepartment of Management Sciences, COMSATS University Islamabad, Park Road, 45550 Islamabad, Pakistan.
Paulo FerreiraVALORIZA-Research Center for Endogenous Resource Valorization, 7300-555 Portalegre, Portugal Department of Economic Sciences and Organizations, Polytechnic Institute of Portalegre.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Stock markets are generally perceived as a barometer of the economy and respond to international monetary policies even before economic activities. Many central banks have turned to unconventional policy measures in response to various financial crises such as the global financial crisis of 2007-2009 or the recent crisis caused by COVID-19. To examine the cross-correlation of overall international monetary policies with stock markets, we employ the daily shadow short rate (SSR), which has the advantage of allowing comparison across unconventional and conventional regimes. The analysis is made through a multifractal context using multifractal detrended cross correlation analysis (MF-DXA), considering daily data from 1st January 2000 to 31st March 2022 and country specific SSR and the stock markets of eight developed economies. The main empirical findings are the following: (i) all the country specific pairs of SSR with stock markets have significant multifractal characteristics (ii) the pairs of NZ-SSR/NZX50, US-SSR/DJIA, and CN-SSR/S&P TSX have the highest multifractal patterns while EU-SSR/Euro-area Index has the lowest multifractal patterns (iii) Australian and New Zealand stock markets exhibit anti-persistent cross-correlation with SSR while the remainder have persistent cross-correlation in their multifractality. Lastly, the findings of this study have several important implications for central banks and stock market participants.

Indexed as

Cross correlationMF-DXAMonetary policyShadow short ratesSSRStock markets

Identifiers

PMID37483712
PMCPMC10362331

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.